Thursday, February 13, 2020

Seqster Gets Investment From Takeda

San Diego-based Seqster, which develops software used fhttps://www.socaltech.com/images/logos/seqster20a.pngor health data management, said today that it has received an investment from Takeda Pharmaceuticals. Size of the investment was not announced. According to Seqster, it will use the new funding to accelerate adoption of its technology, which is used for managing clinical trials and patient engagement. Seqster is led by Ardy Arianpour. The company's software is used during clinical trials for health records, and for patient clinical trial onboarding, monitoring and post-trial follow-ups. The company says its platform is already in use among 3,000 healthcare providers and over 100,000 hospitals and clinics. More information »

---